A Phase II Study of Radiation Therapy Following Nodal Surgery in Malignant Melanoma

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Related Post

Tour de Cure grants for TROG Cancer Research trials
9 January, 2025

Tour de Cure grants support two valuable TROG trials

9 January 2025: Two important TROG Cancer Research trials

7 January, 2025

GenesisCare Foundation $300,000 donation to support TROG work

7 January 2025: TROG Cancer Research is advancing vital